PFE

#98
Pfizer, Inc. Common Stock
26.1 8 USD
+0.46%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
26.07
26.22
Intervallo Annuale
23.06
28.75
Variazione giornaliera
+0.46%
Variazione Mensile
-0.80%
Variazione di 6 mesi
+1.63%
Variazione Annuale
+11.40%
Chiusura Precedente
26.0 6
Open
26.1 0
Minimo
26.0 7
High
26.2 2
Volume
7 045
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 149.21 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
21.2
Rapporto prezzo/fatturato
2.51
Dividendi per azione
—
Rendimento da dividendi %
9.29

Pfizer, Inc. Common Stock

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

Notizie